Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for Localised TNBC By Ogkologos - May 19, 2026 288 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PLANeT study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR FDA Grants Accelerated Approval to Tovorafenib for Patients with Relapsed or... May 2, 2024 HBV Infection Associated with Increased Risk of Primary Extrahepatic Malignancies May 23, 2022 Clinical Activity of Elraglusib with Gemcitabine Plus Nab-paclitaxel in First-Line Treatment... April 27, 2026 New Research in Treating Metastatic Breast Cancer, Preventing Breast Cancer, and... February 7, 2023 Load more HOT NEWS Cómo aprendí a sobrellevar la culpa del superviviente después del cáncer College Basketball Star Plays First Game in Nearly Two Years After... Study Finds Most Women Who ‘Go Flat’ After Mastectomy Are Happy... Better together: improving brain tumour treatment
